Get the Stockscreener App
3.1818
0.79%
0.0218
Annexon Inc stock is traded at $3.1818, with a volume of 1.15M.
It is up +0.79% in the last 24 hours and down -0.16% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$3.16
Open:
$3.2
24h Volume:
1.15M
Relative Volume:
0.64
Market Cap:
$350.54M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.7976
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
-10.03%
1M Performance:
-0.16%
6M Performance:
+61.68%
1Y Performance:
-56.25%
1-Day Range:
$3.09
$3.37
1-Week Range:
$2.89
$3.60
52-Week Range:
$1.285
$7.625
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650)-822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
3.19 | 347.24M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.61 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.67 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.67 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.12 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.31 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Is Annexon Inc. reversing from oversold territory2025 Market Outlook & Community Verified Trade Alerts - newser.com
Is Annexon Inc. stock positioned for long term growthMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Is Annexon Inc. meeting your algorithmic filter criteriaWatch List & Fast Gaining Stock Strategy Reports - newser.com
Analyzing Annexon Inc. with multi timeframe chartsJuly 2025 Trends & Intraday High Probability Alerts - newser.com
Can Annexon Inc. stock deliver consistent earnings growthWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Annexon Inc. recovery potential after sell offPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
How geopolitical tensions affect Annexon Inc. stockWeekly Market Summary & Safe Entry Zone Identification - newser.com
Will Annexon Inc. stock rally after Fed decisionsRate Cut & Fast Entry Momentum Alerts - newser.com
Chart overlay techniques for tracking Annexon Inc.Chart Signals & Proven Capital Preservation Tips - newser.com
Can momentum traders help lift Annexon Inc.2025 Growth vs Value & Weekly Market Pulse Updates - newser.com
Key metrics from Annexon Inc.’s quarterly data2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
Annexon Inc Stock Analysis and ForecastBull Market Opportunities & The Future of Wealth Is Just a Click Away - earlytimes.in
Why Annexon Inc. stock remains undervalued2025 Year in Review & Long-Term Capital Growth Ideas - newser.com
Is Annexon Inc. stock a defensive play in 20252025 Key Lessons & Weekly Top Stock Performers List - newser.com
Why Annexon Inc. stock is favored by top institutions2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
Real time scanner hits for Annexon Inc. explained2025 Technical Overview & Stock Timing and Entry Methods - newser.com
Is Annexon Inc. still worth holding after the dip2025 Stock Rankings & Safe Entry Trade Reports - newser.com
William Carson Buys 4,115 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat
Can Annexon Inc. stock surprise with earnings upsideJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com
Annexon Inc. stock momentum explainedWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - newser.com
How currency fluctuations impact Annexon Inc. stockEarnings Growth Report & Low Drawdown Investment Ideas - newser.com
Should you hold or exit Annexon Inc. nowJuly 2025 Update & AI Powered Market Entry Strategies - newser.com
Insider Buying: William Carson Acquires Additional Shares of Ann - GuruFocus
Will Annexon Inc. stock deliver better than expected guidance2025 Trading Recap & Real-Time Chart Breakout Alerts - newser.com
Is Annexon Inc. stock a buy for dividend growthMarket Volume Summary & Consistent Return Investment Signals - newser.com
Annexon Inc. stock daily chart insights2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
Is it too late to sell Annexon Inc.Trade Analysis Summary & Weekly Market Pulse Updates - newser.com
Is Annexon Inc. stock a safe investment in uncertain markets2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):